MPAM
TECX

Monarch Partners Asset Management’s Tectonic Therapeutic TECX Stock Holding History

Monarch Partners Asset Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,277
Closed -$347K – 177
2021
Q1 		$347K Buy
2,277
+70
+3% +$11.4K 0.05% 149
2020
Q4 		$369K Sell
2,207
-239
-10% -$42.5K 0.06% 167
2020
Q3 		$382K Buy
2,446
+788
+48% +$159K 0.09% 153
2020
Q2 		$347K Buy
+1,658
New +$342K 0.08% 157

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Monarch Partners Asset Management's TECX Position: Q2 2021 in Review

Monarch Partners Asset Management sold out of Tectonic Therapeutic (TECX) in Q2 2021, closing a stake of 2,277 shares — an estimated $347K sold.

Monarch Partners Asset Management first reported a position in TECX in Q2 2020 and held it in 4 quarters. The position peaked at $382K in Q3 2020. 97 funds tracked by Wall St. Rank hold TECX as of Q2 2021.

  • Monarch Partners Asset Management reported no remaining Tectonic Therapeutic position as of Q2 2021 after selling out during the quarter.
  • Monarch Partners Asset Management sold 2,277 Tectonic Therapeutic shares in Q2 2021, an estimated $347K.
  • Monarch Partners Asset Management first reported a position in Tectonic Therapeutic in Q2 2020 and held it in 4 quarters.
  • Monarch Partners Asset Management's Tectonic Therapeutic position peaked at $382K in Q3 2020.
  • 97 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2021.

Based on Monarch Partners Asset Management's 13F filing for Q2 2021, filed 30 Jul 2021.